| Hans-Günter Meyer-Thompson | Buprenorphin
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation.
Experience and response to a randomised controlled trial of extended-release injectable buprenorphine versus sublingual tablet buprenorphine and oral liquid methadone for opioid use disorder: protocol for a mixed-methods evaluation.
Lowry N, Cowden F, Day E, Gilvarry E, Johnstone S, Murray R, Kelleher M, Mitcheson L, Marsden J.
BMJ Open. 2022 Oct 21;12(10):e067194. doi: 10.1136/bmjopen-2022-067194. PMID: 36270754; PMCID: PMC9594511.